These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10602908

  • 1. Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma.
    Clive S, Gardiner J, Leonard RC.
    Cancer Chemother Pharmacol; 1999; 44 Suppl():S29-30. PubMed ID: 10602908
    [Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer.
    Leonard R, Hardy J, van Tienhoven G, Houston S, Simmonds P, David M, Mansi J.
    J Clin Oncol; 2001 Nov 01; 19(21):4150-9. PubMed ID: 11689583
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients.
    Smorenburg CH, Seynaeve C, Bontenbal M, Planting AS, Sindermann H, Verweij J.
    Anticancer Drugs; 2000 Nov 01; 11(10):825-8. PubMed ID: 11142690
    [Abstract] [Full Text] [Related]

  • 4. Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer.
    Terwogt JM, Mandjes IA, Sindermann H, Beijnen JH, ten Bokkel Huinink WW.
    Br J Cancer; 1999 Mar 01; 79(7-8):1158-61. PubMed ID: 10098751
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A phase II trial of miltefosine in patients with cutaneous T-cell lymphoma.
    Dumontet C, Thomas L, Bérard F, Gimonet JF, Coiffier B.
    Bull Cancer; 2006 Nov 01; 93(11):E115-8. PubMed ID: 17145574
    [Abstract] [Full Text] [Related]

  • 11. Loco-regional control of cutaneous metastases of malignant melanoma by treatment with miltefosine (Miltex).
    Ragnarsson-Olding B, Djureen-Mårtensson E, Månsson-Brahme E, Hansson J.
    Acta Oncol; 2005 Nov 01; 44(7):773-7. PubMed ID: 16227173
    [No Abstract] [Full Text] [Related]

  • 12. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients.
    Unger C, Sindermann H, Peukert M, Hilgard P, Engel J, Eibl H.
    Prog Exp Tumor Res; 1992 Nov 01; 34():153-9. PubMed ID: 1438798
    [No Abstract] [Full Text] [Related]

  • 13. Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: Ten-year audit of single centre experience.
    Bourke MG, Salwa SP, Sadadcharam M, Whelan MC, Forde PF, Larkin JO, Collins CG, O'Reilly S, O'Sullivan GC, Clover AJ, Soden DM.
    Breast Cancer Res Treat; 2017 Jan 01; 161(2):289-297. PubMed ID: 27878392
    [Abstract] [Full Text] [Related]

  • 14. Topical calcipotriol treatment in advanced breast cancer.
    Bower M, Colston KW, Stein RC, Hedley A, Gazet JC, Ford HT, Combes RC.
    Lancet; 1991 Mar 23; 337(8743):701-2. PubMed ID: 1672178
    [Abstract] [Full Text] [Related]

  • 15. [Multiple cutaneous plasmocytoma treated with topical applications of miltefosine].
    Viseux V, Schoenlaub P, Danhier S, Vilque JP, Plantin P.
    Ann Dermatol Venereol; 2004 Feb 23; 131(2):204-5. PubMed ID: 15026752
    [No Abstract] [Full Text] [Related]

  • 16. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG, Silva DL, Nunan FA, Nunan EA, Fernandes AP, Ferreira LA.
    J Antimicrob Chemother; 2009 Dec 23; 64(6):1234-40. PubMed ID: 19825819
    [Abstract] [Full Text] [Related]

  • 17. Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial.
    Hartmann K, Siebenhaar F, Belloni B, Brockow K, Eben R, Hartmann B, Ruëff F, Schoepke N, Staubach P, Weber A, Maurer M.
    Br J Dermatol; 2010 Jan 23; 162(1):185-90. PubMed ID: 19785605
    [Abstract] [Full Text] [Related]

  • 18. 4,4'-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007): a topical treatment for cutaneous metastases from malignant cancers.
    Eilender D, LoRusso P, Thomas L, McCormick C, Rodgers AH, Hooper CL, Tornyos K, Krementz ET, Parker S, Morgan LR.
    Cancer Chemother Pharmacol; 2006 Jun 23; 57(6):719-26. PubMed ID: 16184382
    [Abstract] [Full Text] [Related]

  • 19. Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study.
    Dummer R, Krasovec M, Röger J, Sindermann H, Burg G.
    J Am Acad Dermatol; 1993 Dec 23; 29(6):963-70. PubMed ID: 8245262
    [Abstract] [Full Text] [Related]

  • 20. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
    Paolino G, Panetta C, Didona D, Donati M, Donati P.
    Acta Dermatovenerol Croat; 2016 Jun 23; 24(2):154-7. PubMed ID: 27477179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.